The novel therapy of the medication represents a exciting development in the care of the condition. Unlike existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – resulting https://tirzepatide-peptide422509.losblogos.com/40697802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment